BioStem Technologies, Inc.
BSEM
$3.71
$0.102.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -27.95% | -61.57% | -55.49% | -43.12% | 182.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -27.95% | -61.57% | -55.49% | -43.12% | 182.43% |
| Cost of Revenue | 346.38% | 178.42% | -91.51% | -71.58% | -81.72% |
| Gross Profit | -52.90% | -75.13% | -48.83% | -34.61% | 160.29% |
| SG&A Expenses | 45.06% | 35.05% | 67.95% | 33.76% | 131.34% |
| Depreciation & Amortization | 1,035.58% | 900.74% | -12.78% | 6.67% | 14.74% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.22% | 40.14% | 23.47% | -1.06% | 149.05% |
| Operating Income | -7,547.43% | -269.25% | -189.24% | -84.41% | -98.72% |
| Income Before Tax | -5,140.11% | -267.02% | -187.75% | -83.95% | -97.93% |
| Income Tax Expenses | -- | -- | 162.32% | -69.66% | -92.77% |
| Earnings from Continuing Operations | -84,735.85% | -325.68% | -176.78% | -88.84% | -99.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -84,735.85% | -325.68% | -176.78% | -88.84% | -99.83% |
| EBIT | -7,547.43% | -269.25% | -189.24% | -84.41% | -98.72% |
| EBITDA | -4,544.61% | -257.34% | -188.11% | -83.88% | -98.05% |
| EPS Basic | -86,383.33% | -323.29% | -176.48% | -89.13% | -99.84% |
| Normalized Basic EPS | -4,608.96% | -265.29% | -187.40% | -84.36% | -97.97% |
| EPS Diluted | -104,100.00% | -448.93% | -213.60% | -90.63% | -99.83% |
| Normalized Diluted EPS | -6,527.66% | -360.22% | -229.40% | -85.41% | -98.09% |
| Average Basic Shares Outstanding | 3.70% | 1.06% | 0.38% | 2.60% | 2.53% |
| Average Diluted Shares Outstanding | -26.01% | -35.82% | -32.19% | 9.97% | 7.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |